TERAPIO

Basic Information

11412 Bee Cave Rd
Suite 100
AUSTIN, TX, 78738-

http://terapio.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 806143207
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 11


  1. TOPIC 323 PHASE I; DEVELOPMENT OF RADIATION MODULATORS FOR USE DURING RADIOTHERAP

    Amount: $250,000.00

    Oral mucositis (OM) is a common side effect in oncology patients receiving radiation treatment. Mucosal breakdown causes pain which leads to increased use of narcotic analgesics and restriction of foo ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Development of RLIP76 protein as a Radiation Countermeasure

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): There remains a critical need for medicines that can counteract the toxic effects of radiation exposure. Terapio is developing a recombinant protein, RLIP76, ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. Development of RLIP767 as a Radiation Countermeasure

    Amount: $559,128.00

    DESCRIPTION (provided by applicant): A major instigator of radiation-induced pathology is cellular damage caused by reactive oxygen species formed in the first moments after exposure. Most therapeutic ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government